Global Cardiac Resynchronization Therapy Devices Market Report to 2027 - Featuring Medtronic, Boston Scientific and Biotronik Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 20, 2022--

The "Global Cardiac Resynchronization Therapy (CRT) Devices Market - Analysis By Product (CRT-D, CRT-P), End-User By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2022-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 7.14 Billion in the year 2021 with Americas region leading the regional market share.

Company Profiles

• Medtronic PLC
• Boston Scientific
• Abbott Laboratories
• Biotronik
• MicroPort Scientific Corporation
• LivaNova PLC
• Medico S.p.A
• EBR Systems

One of the main factors driving this market is the rising prevalence of cardiovascular diseases (CVDs) that lead to heart failure (HF).

Each year, approximately 3.5 million people suffer from HF worldwide fostering the demand for cardiac resynchronization therapy devices. Additionally, factors such as technological advancements in devices, expanding CRT product developments, key company initiatives & investments, sedentary lifestyles and ageing demographics around the world are anticipated to impel the market growth in the forecast period.

The Asia Pacific CRT devices market is predicted to be the hotspot and the most lucrative region for the market participants worldwide. Some of the major factors propelling the growth of the cardiac resynchronization therapy devices market in the Asia Pacific region include a favourable reimbursement scenario in Japan, an ageing population in China, an increase in CVD incidence, an improved healthcare infrastructure, an expanding middle-class population, and rising disposable income levels in India.

The cardiac resynchronization therapy (CRT) devices market experienced a period of a temporary setback in the year 2020 as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19 virus. However, after the initial shock and confusion about COVID-19, companies and governments began taking corrective actions to help the economy and businesses recover.

These measures included policy & monetary stimulus, easing of restrictions, conditional exemptions, and other strategic initiatives. This resulted in healthcare activities returning to normal pace towards the end of 2020 with the approval and administration of COVID-19 vaccines across the globe, thereby offering better growth prospects for the cardiac resynchronization therapy devices market during the forecast period.

Scope of the Report:

• The report presents the analysis of Cardiac Resynchronization Therapy Devices Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
• The report analyses the Cardiac Resynchronization Therapy Devices Market by value (USD Billion).
• The report analyses the Cardiac Resynchronization Therapy Devices Market by value (USD Billion).
• The report analyses the Cardiac Resynchronization Therapy Devices Market by Product Type (CRT-Defibrillator and CRT-Pacemaker).
• The report analyses the Cardiac Resynchronization Therapy Devices Market by End User (Hospitals, Cardiac Centres and Research & Laboratories).
• The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).
• The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Product and by End User.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

Key Topics Covered:

1. Report Scope and Methodology

2. Strategic Recommendations

3. Cardiac Resynchronization Therapy Devices Market: Product Overview

4. Global Cardiac Resynchronization Therapy Devices Market: An Analysis

5. Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product (Value)

6. Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End User (Value)

7. Global Cardiac Resynchronization Therapy Devices Market: Regional Analysis

8. Americas Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)

9. Europe Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)

10. Asia Pacific Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)

11. MEA Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)

12. Global Cardiac Resynchronization Therapy Devices Market Dynamics

12.1 Global Cardiac Resynchronization Therapy Devices Market Drivers

12.2 Global Cardiac Resynchronization Therapy Devices Market Restraints

12.3 Global Cardiac Resynchronization Therapy Devices Market Trends

13. Market Attractiveness and Strategic Analysis

13. Competitive Landscape

13.1 Market Share of global leading companies

13.2 SWOT Analysis- Global Cardiac Resynchronization Therapy Devices Market

14. Global Cardiac Resynchronization Therapy Devices Market: Competitive Landscape

14.1 Market Share of global leading companies

14.2 Recent Developments and Mergers & Acquisitions

14.3 Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021

15. Company Profiles

16. About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/ntnkap

View source version on businesswire.com:https://www.businesswire.com/news/home/20220920006002/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.